VASCULAR COGNITIVE IMPAIRMENT AND DEMENTIA
With
Jessica Lo,
Research Associate
Centre for Healthy Brain Ageing (CHeBA),
UNSW Sydney
New South Wales, Australia
RESEARCHER PROFILE
Filmed in Sydney, Australia | October 2026
Jessica Lo (Jess) is a Research Associate at the Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney, Australia. For over seven years, she has been instrumental in leading and coordinating research for the international Stroke and Cognition Consortium (STROKOG), collaborating with global experts to address key questions related to vascular cognitive impairment and dementia.
With a strong background in Medical Statistics and extensive experience as a biostatistician, including working on clinical trials at King’s College London, Jess’s research focuses on post-stroke cognitive decline and dementia. She published five first-authored papers in high-impact journals on topics such as the prevalence of post-stroke cognitive impairment across ethno-regional groups and the trajectory of cognitive decline after stroke.
Her work, which has garnered over 1,360 citations, has been featured in international media. Jess has presented her research at more than 10 national and international conferences and has been invited to speak at global events.
Committed to translating her findings into clinical practice, she aims to provide healthcare professionals with evidence-based strategies to prevent or delay the onset of dementia and improve long-term outcomes for stroke survivors.
Source: Supplied
https://orcid.org/0000-0003-4778-8360
-
Influence of gut microbes and inflammation on brain function and behaviour in autism
Third-year PhD candidate Angela Jimenez is part of the Gut-Brain Axis Laboratory at RMIT University in Melbourne, Australia. Angela holds a bachelor’s degree in neuroscience (Honours) from the National Autonomous University of Mexico (UNAM), and her doctoral research is currently supported by the RMIT–Mexico International Scholarship program.
-
CASE STUDY increasing survival, free of bronchopulmonary dysplasia (BPD) in extremely preterm infants
The aim of the PLUSS trial was to find out if installation of budesonide (a steroid) with surfactant to the lungs of extremely preterm babies helps to prevent lung disease, or Bronchopulmonary dysplasia (BPD).
-
Causal genes and pathogenic mechanisms underlying gastrointestinal diseases
Professor D’Amato has more than 25 years research experience in the field of human genetics and complex diseases, with activities most recently geared towards a translational application for therapeutic precision in gastroenterology. His team, the Gastrointestinal Genetics Laboratory, combine leading expertise in genomic, computational and pre-clinical research, and have contributed important breakthroughs linking specific genes and pathogenetic mechanisms to a number of gastrointestinal diseases like inflammatory bowel disease (IBD), microscopic colitis (MC) and irritable bowel syndrome (IBS).
